Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2026-01-04 @ 3:54 PM
Study NCT ID:
NCT00600093
Status:
TERMINATED
Last Update Posted:
2011-07-26
First Post:
2008-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
Sponsor:
Rabin Medical Center
Organization:
Study Overview
Official Title:
Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
Status:
TERMINATED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
PI leaving the institute for a fellowship.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether administrating of Amantadine (a dopamine agonist) to patients suffering from Parkinson disease during the perioperative period is safe, and to asses potential benefits of this treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: